Gland Pharma
Healthcare
Gland Pharma buys assets of Vitane Biologics to boost Sputnik V Covid vaccine production
Generic injectables-focused Gland Pharma Ltd, majority owned by China’s Shanghai Fosun Pharmaceutical Group, said it has acquired the assets of ......
Markets
Indian shares end lower as banks drag; Gland Pharma jumps on vaccine deal
Indian shares gave up early gains to close lower on Tuesday, dragged down by losses in financial stocks, while Gland ......
General
Grapevine: Fosun to buy 2 Pfizer factories; Sunil Mittal to up stake in CG Power
Gland Pharma, owned by Chinese firm Fosun Pharma, has emerged as the front-runner to acquire the two factories in Chennai ......
Finance
KKR strikes year's first full exit from India portfolio
Private equity giant Kohlberg Kravis Roberts & Co. (KKR) has sold its entire stake in a private-sector lender, marking its ......
General
Blackstone among suitors for Orchid Pharma; Greenko eyes Essel's solar assets
Private equity giant Blackstone, drugmakers Strides Shasun and Nectar Lifesciences are ahead in the race to acquire debt-laden Orchid Pharma, ......
Healthcare
Flashback 2017: Pharma M&As hog limelight; multi-speciality hospitals get PE money
Large private equity investments in multi-specialty hospitals and sustained investor interest across the single-specialty space were the showstoppers in the ......
General
Gland Pharma looks to revise Fosun deal; Rosatom eyes Inox's wind turbine biz
The shareholders of Gland Pharma Ltd, including buyout firm KKR and Co., are now considering selling up to 74% under ......
TMT
MakeMyTrip-SAIF Partners is exit of the year: VCCircle Awards
Venture capital and growth equity investment firm SAIF Partners has won the News Corp VCCircle exit of the year award ......
General
Which PE firms scored biggest exit deals
Private equity firms had another bumper year in terms of exits, with stake sale activity most notable in the manufacturing ......
General
M&As emerge the most popular route for PE exits even as the number of deals slides in Q3
The number of private equity exits in the three months ended September hit the lowest in the past 17 quarters ......